{"id":129,"date":"2026-09-22T12:59:35","date_gmt":"2026-09-22T12:59:35","guid":{"rendered":"https:\/\/bimini.jppwebdesign.nl\/?p=129"},"modified":"2026-09-22T12:59:35","modified_gmt":"2026-09-22T12:59:35","slug":"bimini-biotech-secures-eurostars-grant-for-myelo-wasp-project-to-develop-first-in-class-leukemia-therapeutics","status":"publish","type":"post","link":"https:\/\/bimini.jppwebdesign.nl\/?p=129","title":{"rendered":"BIMINI Biotech secures Eurostars grant for MYELO-WASP project to develop first-in-class leukemia therapeutics"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Leiden, 9 April 2026.<\/strong> The MYELO-WASP project has been awarded funding through the Eureka Eurostars programme to advance first-in-class small molecules targeting Wiskott-Aldrich Syndrome Protein (WASp) for myeloid and lymphoid leukaemias.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The \u20ac2.2 million international project is led by BIMINI Biotech in the Netherlands, together with the Institute of Oncology Research in Switzerland and Navegador Biosciences in Portugal.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Advancing WASp-targeting therapeutics<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">MYELO-WASP will progress the translational preclinical development of BIMINI&#8217;s proprietary small-molecule WASp modulators. The programme will also investigate responsive leukaemia subtypes and predictive biomarkers to support patient stratification and future clinical development.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The intended outcome is a comprehensive preclinical data package supporting CTA-enabling development and first-in-human studies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The programme addresses an important unmet need in acute myeloid leukaemia and other blood cancers, where relapse remains common and new treatment mechanisms are needed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Maurits van den Nieuwboer, COO of BIMINI Biotech, said the consortium will help bring BIMINI&#8217;s discoveries closer to clinical development. Prof. Francesco Bertoni of the Institute of Oncology Research and Peter Dmitriev of Navegador Biosciences emphasised the value of combining expertise across the European consortium.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Eurostars is part of the European Partnership on Innovative SMEs and is co-funded by the European Union through Horizon Europe.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">About BIMINI Biotech<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">BIMINI Biotech is a preclinical-stage biotechnology company based in Leiden, developing first-in-class small-molecule therapeutics targeting WASp.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Leiden, 9 April 2026. The MYELO-WASP project has been awarded funding through the Eureka Eurostars programme to advance first-in-class small molecules targeting Wiskott-Aldrich Syndrome Protein (WASp) for myeloid and lymphoid leukaemias. The \u20ac2.2 million international project is led by BIMINI Biotech in the Netherlands, together with the Institute of Oncology Research in Switzerland and Navegador [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-129","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/bimini.jppwebdesign.nl\/index.php?rest_route=\/wp\/v2\/posts\/129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bimini.jppwebdesign.nl\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bimini.jppwebdesign.nl\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bimini.jppwebdesign.nl\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bimini.jppwebdesign.nl\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=129"}],"version-history":[{"count":1,"href":"https:\/\/bimini.jppwebdesign.nl\/index.php?rest_route=\/wp\/v2\/posts\/129\/revisions"}],"predecessor-version":[{"id":130,"href":"https:\/\/bimini.jppwebdesign.nl\/index.php?rest_route=\/wp\/v2\/posts\/129\/revisions\/130"}],"wp:attachment":[{"href":"https:\/\/bimini.jppwebdesign.nl\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bimini.jppwebdesign.nl\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bimini.jppwebdesign.nl\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}